Neurology Minute

Latest Episodes:

Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core - Part 2 Aug 13, 2024

Show notes

In part two of this two-part series, Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the differences in treatment between American Stroke Centers and those in France.

Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398

Transient Smartphone Blindness Aug 12, 2024

Show notes

Dr. Meagan Seay discusses a relatively recently described but very interesting phenomenon called transient smartphone blindness. This is a phenomenon causing acute, painless, transient, monocular vision loss associated with smartphone use while lying down in the dark.

Show reference:

Transient Smartphone Blindness - EyeWiki

Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core Aug 09, 2024

Show notes

Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the efficacy and safety of both thrombolytics in patients with large ischemic core.

Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398

The Ethical Landscape of Prodromal Parkinson Disease Aug 08, 2024

Show notes

Dr. Jason Crowell and Dr. Colin Hoy discuss the concept of prodromal Parkinson disease and the ethical considerations surrounding its diagnosis.

Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209522

Movement Disorders Emergencies - Part 3 Aug 07, 2024

Show notes

In the last episode of this three-part series, Dr. Jeff Ratliff discusses how to approach patients presenting with emergent rigidity and difficulty moving.

Movement Disorders Emergencies - Part 2 Aug 06, 2024

Show notes

In the second episode of this three-part series, Dr. Jeff Ratliff provides a rapid overview of hyperkinetic disorders that require urgent attention.

Movement Disorders Emergencies - Part 1 Aug 05, 2024

Show notes

In the first episode of this three-part series, Dr. Jeff Ratliff discusses a few key points to help recognize and initiate treatment for patients with movement disorder emergencies, focusing on the initial approach to these disorders. It is important to consider medications, labs, and imaging as part of the evaluation process.

Association of Prenatal Exposure to Antiseizure Medications Aug 02, 2024

Show notes

Dr. Halley Alexander and Dr. Kimford Meador discuss perinatal exposure to anti-seizure medications and its effects on creativity and executive function in children.

Show reference:

https://www.neurology.org/doi/10.1212/WNL.0000000000209448

Tapping the Brakes on New Parkinson Disease Biological Staging Aug 01, 2024

Show notes

Dr. Matthew Barrett and Dr. Michael S. Okun discuss the caution and deliberation needed in understanding Parkinson disease biomarkers.

Show reference:

https://jamanetwork.com/journals/jamaneurology/article-abstract/2820441

Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 2 Jul 31, 2024

Show notes

In the final episode of this two-part series, Dr. Joe Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Ravulizumab + zilucoplan.

Show references:

https://doi.org/10.1016/s1474-4422(21)00159-9

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected